Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ g4_DEBh
oqHI
`Tu
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© Mh>H
5l.1i
7. 9n
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© (Y\aV+9[
~aa`Y0Ws],
1.Co-stimulators (or co-stimulating molecules) LF?83P,UJ#
>up'`K,
2.NK-kB C"_f3[Z
X64OX9:YF
3.Immunoglobulin superfamily W+V#z8K
/~V.qisZ
4.antigen-presenting cell (APC) B5
pMcw
ww82)m8
5.death domain ivsp):W
#z 3tSnmp
6.CCR and CXCR dHc38zp
,A9pj k'
7.Lectin (or mitogen) 5*~Mv<#
+,<\LIP
8.Clusters of differentiation, CD) 2j8^Z
?#idmb}(
9.B7 family SHS:>V
[,)yc/{*
10.Cytotoxic T lymphocyte, CTL) YP{)jAK
qW[p .jN
11.IL-15 and IL-15 receptor (IL-15R) 1xg^;3m2
FLdO
12.MHC restriction
p%
ESp&
Bi2be$nV
13.Affinity-chromatography
N8|=K_;&
=\.Oc+p4
14.Cyctosprin A, CsA itb0dF1G
2MwRjh_
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ]bCeJE.+)
Z#YkAQHv5
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© O~F/{:U
<r]7xsr
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 %\#s@8=2u
-G&>b
D
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ ^p(t*%LM
?P4@U9i
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 -C.x;@!k
(UmoG
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© _Ki
aeVE
v<iMlOEt
ÃâÒßѧרҵ£º V3baEy>=z
2zR*`9$
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 1L1_x'tT%
f'aQ T
Ïû»¯ÄÚ¿Æ£º (;YO]U4
|qbCmsY5/
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ /9dV!u!;
'8>h4s4
ѪҺ²¡Ñ§×¨Òµ£º
c 2j?<F1
BX$t |t;!m
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿